Dickkopf-1: A Promising Target for Cancer Immunotherapy

Clinical studies in a range of cancers have detected elevated levels of the Wnt antagonist Dickkopf-1 (DKK1) in the serum or tumors of patients, and this was frequently associated with a poor prognosis. Our analysis of DKK1 gene profile using data from TCGA also proves the high expression of DKK1 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Hang Yin, Chen, Zihao, Wang, Luyao, Zhang, Zong-Kang, Tan, Xinhuan, Liu, Shuangshuang, Zhang, Bao-Ting, Lu, Aiping, Yu, Yuanyuan, Zhang, Ge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174842/
https://www.ncbi.nlm.nih.gov/pubmed/34093545
http://dx.doi.org/10.3389/fimmu.2021.658097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174842/
https://www.ncbi.nlm.nih.gov/pubmed/34093545
http://dx.doi.org/10.3389/fimmu.2021.658097

Ejemplares similares